S1800D
|
SWOG
|
A Phase II/III Study of N-803 (ALT-803) Plus Pembrolizumab Versus Standard of Care in Participants with Stage IV or Recurrent Non-Small Cell Lung Cancer Previously Treated with Anti-PD-1 or Anti-PD-L1 Therapy (Lung-MAP Non-Match Sub-Study)
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
S1801
|
SWOG
|
A Phase II Randomized Study of Adjuvant versus Neoadjuvant MK-3475 (Pembrolizumab) for Clinically Detectable Sage III-IV High Risk Melanoma
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
S1802
|
SWOG
|
Phase III Randomized Trial of Standard Systemic Therapy (SST) versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
S1803
|
SWOG
|
Phase III Study of Daratumumab/rHuPH20 (NSC-810307) + Lenalidomide or Lenalidomide as Post-Autologous Stem Cell Transplant Maintenance Therapy in Patients with Multiple Myeloma (MM) using Minimal Residual Disease to Direct Therapy Duration (DRAMMATIC STUDY)
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
S1806
|
SWOG
|
Phase III Randomized Trial of Concurrent Chemoradiotherapy with or without Atezolizumab in Localized Muscle Invasive Bladder Cancer
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
S1815
|
SWOG
|
A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
S1820
|
SWOG
|
A Randomized Trial of the Altering Intake, Managing Symptoms Intervention for Bowel Dysfunction in Rectal Cancer Survivors Compared to a Healthy Living Education Control: A Feasibility and Preliminary Efficacy Study (AIMS-RC)
|
Cancer Prevention and Control CIRB
|
Available to Open
|
|
S1823
|
SWOG
|
A Prospective Observational Cohort Study To Assess miRNA 371 For Outcome Prediction in Patients With Newly Diagnosed Germ Cell Tumors
|
Cancer Prevention and Control CIRB
|
Available to Open
|
|
S1826
|
SWOG
|
A Phase III, Randomized Study of Nivolumab (Opdivo) plus AVD or Brentuximab Vedotin (Adcetris) plus AVD in Patient (Age >/= 12 Year) with Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
S1827
|
SWOG
|
MRI Brain Surveillance Alone versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|